Copyright: ©Author(s) 2026.
World J Crit Care Med. Jun 9, 2026; 15(2): 118428
Published online Jun 9, 2026. doi: 10.5492/wjccm.v15.i2.118428
Published online Jun 9, 2026. doi: 10.5492/wjccm.v15.i2.118428
Table 1 Platforms used in metabolomics studies of sepsis and septic shock
| Analytical platform | Metabolite coverage | Major advantages | Key limitations | Relevance in sepsis research |
| ¹H nuclear magnetic resonance | Organic acids, amino acids, sugars, selected lipids | High reproducibility; minimal sample preparation; quantitative; non-destructive | Lower sensitivity; limited detection of low- prevalence metabolites | Metabolic pattern recognition, disease stratification, longitudinal monitoring |
| Gas chromatography-mass spectrometry | Volatile and derivatized metabolites, organic acids, short-chain fatty acids | Excellent chromatographic resolution; robust compound identification | Derivatization required; limited to volatile/semi-volatile compounds | Assessment of microbial-derived metabolites and energy metabolism |
| Liquid chromatography-mass spectrometry | Lipids, acylcarnitines, amino acids, bile acids, microbial metabolites | High sensitivity; broad metabolite coverage; targeted and untargeted analysis | Ion suppression; batch effects; requires rigorous standardization | Biomarker discovery, prognostic modeling, metabolic phenotyping |
- Citation: Mishra A, Juneja D. Metabolic footprint of sepsis and septic shock: A narrative review. World J Crit Care Med 2026; 15(2): 118428
- URL: https://www.wjgnet.com/2220-3141/full/v15/i2/118428.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v15.i2.118428